KR20130130377A - Promoter variant of sod gene derived from coryneform bacteria and method for producing l-lysine using the promoter variant - Google Patents
Promoter variant of sod gene derived from coryneform bacteria and method for producing l-lysine using the promoter variant Download PDFInfo
- Publication number
- KR20130130377A KR20130130377A KR1020120054145A KR20120054145A KR20130130377A KR 20130130377 A KR20130130377 A KR 20130130377A KR 1020120054145 A KR1020120054145 A KR 1020120054145A KR 20120054145 A KR20120054145 A KR 20120054145A KR 20130130377 A KR20130130377 A KR 20130130377A
- Authority
- KR
- South Korea
- Prior art keywords
- gene
- promoter
- seq
- sod
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 title claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 241000186031 Corynebacteriaceae Species 0.000 title claims abstract description 10
- 101150017120 sod gene Proteins 0.000 title abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 80
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 38
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 38
- 239000004472 Lysine Substances 0.000 claims abstract description 30
- 239000013598 vector Substances 0.000 claims abstract description 30
- 235000019766 L-Lysine Nutrition 0.000 claims abstract description 29
- 235000001014 amino acid Nutrition 0.000 claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 238000012258 culturing Methods 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 19
- 239000002773 nucleotide Substances 0.000 claims description 19
- 125000003729 nucleotide group Chemical group 0.000 claims description 19
- 229940024606 amino acid Drugs 0.000 claims description 11
- 101150057904 ddh gene Proteins 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 8
- 241000186216 Corynebacterium Species 0.000 claims description 8
- 108010056578 diaminopimelate dehydrogenase Proteins 0.000 claims description 8
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims description 7
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims description 7
- 238000002744 homologous recombination Methods 0.000 claims description 7
- 230000006801 homologous recombination Effects 0.000 claims description 7
- 101710088194 Dehydrogenase Proteins 0.000 claims description 6
- 108010055400 Aspartate kinase Proteins 0.000 claims description 5
- 108091026890 Coding region Proteins 0.000 claims description 5
- 101150107204 asd gene Proteins 0.000 claims description 5
- 101150034124 ask gene Proteins 0.000 claims description 5
- 101150057497 fbp gene Proteins 0.000 claims description 5
- 101150014950 gnd gene Proteins 0.000 claims description 5
- 101150016257 pycA gene Proteins 0.000 claims description 5
- 101150078419 zwf gene Proteins 0.000 claims description 5
- 102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 4
- 108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 4
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 4
- 108010064711 Homoserine dehydrogenase Proteins 0.000 claims description 4
- 101150024271 TKT gene Proteins 0.000 claims description 4
- 102000014701 Transketolase Human genes 0.000 claims description 4
- 108010043652 Transketolase Proteins 0.000 claims description 4
- 101150070145 aspB gene Proteins 0.000 claims description 4
- 210000000349 chromosome Anatomy 0.000 claims description 4
- 101150073654 dapB gene Proteins 0.000 claims description 4
- 229940050410 gluconate Drugs 0.000 claims description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 3
- 108030003594 Diaminopimelate decarboxylases Proteins 0.000 claims description 3
- 108010053763 Pyruvate Carboxylase Proteins 0.000 claims description 3
- 102000027487 Fructose-Bisphosphatase Human genes 0.000 claims description 2
- 108010017464 Fructose-Bisphosphatase Proteins 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- HOSWPDPVFBCLSY-UHFFFAOYSA-N 2-azaniumyl-4-oxobutanoate Chemical compound OC(=O)C(N)CC=O HOSWPDPVFBCLSY-UHFFFAOYSA-N 0.000 claims 1
- 102000004867 Hydro-Lyases Human genes 0.000 claims 1
- 108090001042 Hydro-Lyases Proteins 0.000 claims 1
- 101150078994 La gene Proteins 0.000 claims 1
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 claims 1
- 101150033534 lysA gene Proteins 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000000855 fermentation Methods 0.000 abstract description 4
- 230000004151 fermentation Effects 0.000 abstract description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 235000018977 lysine Nutrition 0.000 abstract 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 31
- 108020004414 DNA Proteins 0.000 description 26
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 239000012634 fragment Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 6
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 229930027917 kanamycin Natural products 0.000 description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
- 229960000318 kanamycin Drugs 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 241000186254 coryneform bacterium Species 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000001712 DNA sequencing Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007376 cm-medium Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- -1 Fe SOD Proteins 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000003028 enzyme activity measurement method Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000337023 Corynebacterium thermoaminogenes Species 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 241000319304 [Brevibacterium] flavum Species 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 101150011371 dapA gene Proteins 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- ACIOXMJZEFKYHZ-BXKDBHETSA-N (6r,7r)-7-amino-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)N)CC=1C[N+]1=CC=CC=C1 ACIOXMJZEFKYHZ-BXKDBHETSA-N 0.000 description 1
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- JUQLUIFNNFIIKC-UHFFFAOYSA-N 2-aminopimelic acid Chemical compound OC(=O)C(N)CCCCC(O)=O JUQLUIFNNFIIKC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 101100032149 Bacillus subtilis (strain 168) pyc gene Proteins 0.000 description 1
- 108020004513 Bacterial RNA Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 241000186312 Brevibacterium sp. Species 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 241000595586 Coryne Species 0.000 description 1
- 241000133018 Corynebacterium melassecola Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 101150020960 asp gene Proteins 0.000 description 1
- JGGLZQUGOKVDGS-VYTIMWRQSA-N aspartate semialdehyde Chemical compound O[C@@H]1[C@@H](NC(=O)C)CO[C@H](CO)[C@H]1O[C@@H]1[C@@H](NC(C)=O)[C@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O[C@@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O)[C@@H](O)[C@H](CO[C@@H]3[C@H]([C@H](O[C@@H]4[C@H]([C@H](O)[C@@H](O)[C@H](CO)O4)O)[C@@H](O)[C@H](CO)O3)O)O2)O)[C@H](CO)O1 JGGLZQUGOKVDGS-VYTIMWRQSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000001486 biosynthesis of amino acids Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940046414 biotin 1 mg Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 101150021123 msrA gene Proteins 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000012802 pre-warming Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 229940088174 thiamine 1 mg Drugs 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 코리네형 세균 유래의 슈퍼옥사이드 디스뮤타제(SOD)를 코딩하는 유전자(sod 유전자)의 프로모터 변이체, 상기 프로모터 변이체를 포함하는 재조합 벡터, 상기 재조합 벡터로 형질전환된 숙주세포, 및 상기 숙주세포를 이용하여 배양하는 단계를 포함하는 L-라이신의 발효 생산방법에 관한 것으로, 상기 sod 유전자의 프로모터 변이체가 삽입된 숙주세포를 이용하여, 모균주보다 아미노산의 생합성을 강화시킴으로써, L-라이신과 같은 아미노산의 발효 생산증대 효과를 갖는다.The present invention provides a recombinant vector comprising a promoter mutant of a gene (sod gene) encoding a superoxide dismutase (SOD) derived from coryneform bacteria, a recombinant vector comprising the promoter mutant, a host cell transformed with the recombinant vector, Lysine and a method for producing L-lysine by culturing the same using a host cell, wherein the host cell in which the promoter mutant of the sod gene is inserted is used to enhance the biosynthesis of the amino acid rather than the parent strain, And has the effect of increasing the fermentation production of the same amino acid.
Description
본 발명은 코리네형 세균 유래 sod 유전자의 프로모터 변이체 및 상기 프로모터 변이체를 이용한 L-라이신의 생산 방법 및 상기 프로모터 변이체를 이용한 L-라이신의 생산 방법에 관한 것으로, 보다 상세하게는 코리네형 세균 유래의 슈퍼옥사이드 디스뮤타제(SOD)를 코딩하는 유전자(이하, "sod 유전자"라 한다)의 프로모터 변이체, 상기 프로모터 변이체를 포함하는 재조합 벡터, 상기 재조합 벡터로 형질전환된 숙주세포, 및 상기 숙주세포를 이용하여 배양하는 단계를 포함하는 L-라이신의 생산방법에 관한 것이다. The present invention relates to a promoter mutant of a sory gene derived from a coryneform bacterium, a method for producing L-lysine using the promoter mutant, and a method for producing L-lysine using the promoter variant, and more particularly, A promoter mutant of a gene encoding an oxidized dismutase (SOD) (hereinafter referred to as "sod gene"), a recombinant vector containing the promoter mutant, a host cell transformed with the recombinant vector, And culturing the L-lysine.
코리네형 세균은 그람 양성균이며, 높은 GC 함량을 갖는다. C. glutamicum은 1957년에 토양에서 분리되었는데, 바이오틴 제한(biotin limitation) 방법에 의해 글루타메이트를 생산하는 특징을 보이고, 세포분열시 굽어지는 특징을 가지고 있으며 포자를 형성하지 못하는 균으로 알려져 있다. Coryneform bacteria are Gram-positive bacteria and have high GC content. C. glutamicum was isolated from soil in 1957. It is characterized by the production of glutamate by biotin limitation method, has a characteristic of being bent during cell division and does not form spores.
상기 코리네형 세균은 대표적으로 널리 이용되는 산업용 균으로 적절한 배양조건에서 대사산물을 많은 양으로 분비할 수 있는 능력을 지니고 있기 때문에,L-라이신, L-아르기닌, L-트레오닌 등의 다양한 아미노산 및 핵산 등의 생산에 유용하게 이용되고 있다. The coryneform bacterium is a widely used industrial bacterium, and since it has an ability to secrete a large amount of metabolites under appropriate culture conditions, it can be used as a microorganism in a variety of amino acids such as L-lysine, L-arginine and L- And the like.
그 중, L-라이신은 사람이나 동물의 체내에서 합성되지 않는 필수 아미노산으로서, 식품, 의약 그리고 사료첨가용으로 사용되고 있다. 이처럼 L-라이신을 산업적으로 생산하는 것이 경제적으로 중요한 사업공정이므로, L-라이신 생산 효율을 증대하기 위한 다양한 방법이 연구되어 왔다. Among them, L-lysine is an essential amino acid which is not synthesized in human or animal body, and is used for food, medicine, and feed additive. Since industrial production of L-lysine is an economically important business process, various methods for increasing L-lysine production efficiency have been studied.
50년대 이후 L-라이신의 생합성 경로가 연구된 이래 현재 대부분이 코리네박테리움 속(Corynebacteriun sp.)과 브레비박테리움 속(Brevibacterium sp.)를 이용한 발효에 의해 생산되고, 이후 꾸준히 L-라이신의 생산량이 증대되고 있으며, 세계적으로 L-라이신의 시장은 매년 5% 이상 증가하고 있다 (Kalinowski et al.,2003. J Biotechnol 104: 5-25, Patek et al.1994. Appl. Environ. Microbiol. 60:133-140). Since the biosynthetic pathway of L-lysine has been studied since the 1950's, most of it has now been produced by fermentation with the genus Corynebacteriun sp. And Brevibacterium sp. And the market for L-lysine is increasing by more than 5% per year worldwide (Kalinowski et al., 2003. J Biotechnol 104: 5-25, Patek et al. 1994. Appl. Environ Microbiol. 60: 133-140).
코리네형 세균 균주를 이용하여 L-라이신의 생산을 증대시키기 위하여 고전적인 돌연변이(classical mutagenesis)를 통해 돌연변이 균주를 얻거나 발효조건들을 개선하고 있으며, 유전공학을 통한 L-라이신 생합성 경로 관련 유전자의 증폭, 다른 경로의 유전자 결실 등의 방법이 이용되었으며(유럽공개특허 제0733710호1), 한국공개특허 제2010-20140호, 제2008-8620호 및 제2008-10073호에 따르면, L-라이라이신 생산에 관련된 유전자인 아스파테이트 아미노트랜스퍼라아제, 아스파테이트키나제, 디아미노피멜레이트 디하이드로게나제의 프로모터를 변형시켜 그 유전자의 발현을 증대시키는 방법이 이용되었다.In order to increase production of L-lysine using coryneform bacterial strains, mutant strains are obtained through classical mutagenesis or fermentation conditions are improved, and amplification of genes related to L-lysine biosynthetic pathway through genetic engineering And other methods of gene deletion have been used (European Patent No. 0737101), and according to Korean Patent Publication Nos. 2010-20140, 2008-8620 and 2008-10073, production of L-lysine The method of modifying the promoters of aspartate aminotransferase, aspartate kinase and diaminopimelate dehydrogenase which are related genes to increase the expression of the gene was used.
SOD(superoxide dismutase, Gene ID:1020869)는 슈퍼옥사이드 라디칼(superoxide radical)을 O2와 H2O2로 디스뮤테이션을 촉매하는 효소로 알려져 있으며, 상기 효소는 조효소(cofactor)에 따라 Cu/Zn SOD, Fe SOD, Mn SOD와 Ni SOD 등이 알려져 있으며, 세균에서 발견되는 SOD는 Mn SOD와 Fe SOD가 대부분으로 세포질에 존재하는 것으로 알려져 있다 (Tainer and Getzoff, 1983. Nature 306:284-287). SOD (superoxide dismutase, Gene ID: 1020869) is known as an enzyme that catalyzes the dismutation of superoxide radicals with O 2 and H 2 O 2. The enzymes are Cu / Zn SOD, Fe SOD, Mn SOD and Ni SOD are known, and SOD found in bacteria is mostly found in the cytoplasm of Mn SOD and Fe SOD (Tainer and Getzoff, 1983. Nature 306: 284-287) .
이에 반하여, 병원성 세균의 경우는 숙주의 ROS 공격에 대한 방어 및 공격과 관련하여 Cu/Zn SOD 효소로 주로 주변 세포질(periplasm)에 존재하는 것으로 알려져 있다. 즉, Cu/Zn SOD는 진핵세포와 병원성 및 인체 내부 공생 세균에서 발견되는데 반하여, Fe/Mn SOD는 원핵세포, 원생생물, 미토콘드리아에서 확인된다 (Borgstahl et al., 1992 Cell 71:107-118). 이외에도 Ni-hooked SOD (Barondeau et al., 2004 Biochem. 43(25):8038-8047)와 설페이트 환원 세균인 Desulfo vibrio에서 non-classical SODs 등이 보고되었다 (Silva et al., 1999 Eur.J.Biochem.259:235).On the contrary, in the case of pathogenic bacteria, it is known that Cu / Zn SOD enzyme mainly exists in the periplasm in relation to defense and attack against host ROS attack. That is, Cu / Zn SOD is found in eukaryotes and pathogenic and human symbiotic bacteria, whereas Fe / Mn SOD is found in prokaryotic cells, protists, and mitochondria (Borgstahl et al., 1992 Cell 71: 107-118). . In addition, Ni-hooked SOD (Barondeau et al., 2004 Biochem. 43 (25): 8038-8047) and sulfate reducing bacteria Desulfo Non-classical SODs have been reported in vibrio (Silva et al., 1999 Eur. J. Biochem. 259: 235).
Escherichia coli의 SOD는 2개의 이소자임(isoenzyme)으로 호기성/혐기성 상태에서는 Fe SOD가, 그리고 호기적 상태 하에서는 Mn SOD 만이 나타난다고 보고되었고(Hassen and Fridovich. 1977 Fed. Proc. 36:715), SOD 유전자 조절에 fur(ferric uptake regulation)등이 관여 한다고 알려져 있다 (Tardat and Touati, 1993 Mol Microbiol. 9(1)53-63). Escherichia The SOD of coli is reported to be two isozymes, with Fe SOD in aerobic and anaerobic states and only Mn SOD in aerobic conditions (Hassen and Fridovich. 1977 Fed. Proc. 36: 715). It is known that fur (ferric uptake regulation) is involved in the regulation (Tardat and Touati, 1993 Mol Microbiol. 9 (1) 53-63).
세균에 있어서, 산화성 스트레스(oxidative stress)와 관련된 SOD 연구는 E.coli 이후 Lactococcus lactis (Sanders et al., 1995 J. Bacteriol. 177:5254-5260), Vibrio species (Kimoto et al., 2001 Microbiol.Immunol.45:135-142), Porphyromonas gingivalis (Ohara et al., 2006 Microbiology. 152:955-966), Corynebacterium melassecola (Merkamm and Guyonvarch, 2001 J. Bacteriol. 183(4):1284), Corynebacterium glutamicum (Shafey et al., 2008 Microbiol. Res. 163:80-86), Staphylococcus aureus (2009 J. Bacteriol. 191(10):3301), Helicobacter pylori (2009 J. Agric. Food Chem., 57(17):7743) 등이 보고되었다. In bacteria, SOD studies related to oxidative stress have been reported in Lactococcus after E. coli lactis (Sanders et al., 1995 J. Bacteriol. 177: 5254-5260), Vibrio species (Kimoto et al., 2001 Microbiol. Immunol. 45: 135-142), Porphyromonas gingivalis (Ohara et al., 2006 Microbiology. 152: 955-966), Corynebacterium melassecola (Merkamm and Guyonvarch, 2001 J. Bacteriol. 183 (4): 1284), Corynebacterium glutamicum (Shafey et al., 2008 Microbiol. Res. 163: 80-86), Staphylococcus aureus (2009 J. Bacteriol. 191 (10): 3301), Helicobacter pylori (2009 J. Agric. Food Chem., 57 (17): 7743).
이들 중, SOD 발현에 관한 레귤레이터에 대한 연구까지 알려진 경우도 있지만, 대부분의 균종에 있어서는 SOD 효소 정제 및 효소특성의 연구 단계에 있다. 하지만, 이 유전자 발현 제어에 중요한 역할을 하는 프로모터에 대한 연구가 아직 미비하고, 이 유전자의 프로모터 영역을 예측하고 이 프로모터 개량에 관한 연구결과는 아직 보고된 바가 없다. Among them, studies on regulators for SOD expression are known, but in most species, SOD enzyme purification and enzyme properties are under study. However, studies on the promoters that play an important role in controlling gene expression are still incomplete, and the results of predicting the promoter region of the gene and improving the promoter have not been reported yet.
본 발명자들은 상기와 같은 종래기술의 한계를 해결하기 위하여 연구를 수행하던 중, 코리네형 세균 유래 sod 유전자의 프로모터 부위를 결정하고, 상기 프로모터 부위를 변이시킨 프로모터 변이체를 통하여 프로모터의 활성을 측정한 결과, 내재적 활성보다 증가된 신규한 sod 유전자 프로모터 변이체를 제공할 수 있음을 알아내고, 본 발명을 완성하였다. The inventors of the present invention, while conducting research to solve the above limitations of the prior art, determine the promoter region of the coryneform bacteria-derived sod gene, and measure the activity of the promoter through a promoter variant mutated the promoter region. The inventors have found that they can provide novel sod gene promoter variants that are increased over intrinsic activity, and have completed the present invention.
따라서, 본 발명의 목적은 신규한 코리네형 세균 유래 sod 유전자의 프로모터 변이체를 제공하고, 상기 프로모터 변이체의 증가된 활성을 이용하여 L-라이신 등과 같은 아미노산을 대량 생산할 수 있는 방법을 제공하는 것이다.Accordingly, an object of the present invention is to provide a promoter variant of a novel coryneform bacteria-derived sod gene, and to provide a method for mass production of amino acids such as L-lysine using the increased activity of the promoter variant.
본 발명은 상기와 같은 목적을 달성하기 위하여, 서열번호 1, 서열번호 2, 서열번호 3 및 서열번호 4로 이루어진 군에서 선택되는 어느 하나 이상의 뉴클레오티드 서열을 포함하는, 코리네형 세균 유래의 SOD를 코딩하는 유전자(sod 유전자)의 프로모터 변이체를 제공한다. The present invention encodes SOD derived from coryneform bacteria, including any one or more nucleotide sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4 to achieve the above object It provides a promoter variant of the gene (sod gene).
또한, 본 발명은 상기 프로모터 변이체를 포함하는 재조합 벡터를 제공한다. The present invention also provides a recombinant vector comprising the promoter variant.
또한, 본 발명은 상기 재조합 벡터로 형질전환된 숙주세포를 제공한다. The present invention also provides a host cell transformed with the recombinant vector.
또한, 본 발명은 상기 숙주세포를 이용하여 배양하는 단계를 포함하는 아미노산의 생산방법을 제공한다. In addition, the present invention provides a method for producing an amino acid comprising the step of culturing using the host cell.
본 발명에 의한 코리네형 세균 유래 sod 유전자의 프로모터 변이체는, 디아미노피멜레이트 디하이드로게나제를 코딩하는 유전자(ddh 유전자), 아스파르토키나아제를 코딩하는 유전자(ask 유전자), 트랜스케톨라제를 코딩하는 유전자(tkt 유전자), 디하이드로피콜레이트 씬타아제를 코딩하는 유전자(dapA 유전자), 디하이드로피콜레이트 리덕타아제를 코딩하는 유전자(dapB 유전자), 디아미노피멜레이트 디카르복실라아제를 코딩하는 유전자(lysA 유전자), 아스파르트 세미알데하이드를 코딩하는 유전자(asd 유전자), 아스파테이트 트랜스아미나아제를 코딩하는 유전자(aspB 유전자), 글루코즈 6-포스페이트 디하이드로게나아제를 코딩하는 유전자(zwf 유전자), 포스페이트 글루코네이트 디하이드로게나아제를 코딩하는 유전자(gnd 유전자), 프럭토오즈 비스포스파타아제를 코딩하는 유전자(fbp 유전자), 피루베이트 카르복실라아제를 코딩하는 유전자(pycA 유전자)로 이루어진 군에서 선택되는 1종 이상인 목적 유전자의 코딩 서열과 작동 가능하게 연결됨으로써, 발현되는 효소의 활성이 증가될 수 있다. The promoter mutant of the sod gene derived from a coryneform bacterium according to the present invention is a gene encoding a diaminopimelate dehydrogenase (ddh gene), a gene encoding an aspartokinase (ask gene), a transketolase coding (DapA gene) encoding a dihydropicolate synthase, a gene (dapB gene) encoding a dihydropicolinate dehydrogenase, a gene encoding a diaminopimelate decarboxylase (Asd gene) encoding an aspartate transaminase (aspB gene), a gene encoding a glucose 6-phosphate dehydrogenase (zwf gene), a gene coding for an aspartate transaminase A gene coding for gluconate dehydrogenase (gnd gene), a fructose bspspar The activity of an enzyme expressed by being operably linked with a coding sequence of one or more genes of interest selected from the group consisting of an enzyme coding gene (fbp gene) and a pyruvate carboxylase gene (pycA gene) This can be increased.
또한, 본 발명은 상기 sod 유전자의 프로모터 변이체가 삽입된 숙주세포를 이용하여, 모균주보다 L-라이신과 같은 아미노산의 생합성을 과발현시킴으로써, L-라이신과 같은 아미노산의 생산증대 효과를 갖는다. In addition, the present invention has an effect of increasing the production of amino acids such as L-lysine by overexpressing the biosynthesis of amino acids such as L-lysine than the parent strain by using the host cell into which the promoter variants of the sod gene are inserted.
도 1은 sod 유전자의 프로모터의 영역을 나타내는 도면이다.
도 2는 본 발명에 사용된 벡터의 기본구조인 코리네박테리움 염색체 삽입용 벡터 pK19mobsacB를 나타내는 도면이다.
도 3은 코리네박테리움 염기치환용 벡터 pCGDH를 나타내는 도면이다.1 is a diagram showing a region of a promoter of sod gene.
Figure 2 is a diagram showing a vector pK19mobsacB for Corynebacterium chromosome insertion, which is the basic structure of the vector used in the present invention.
3 is a diagram showing a vector for corynebacterium base substitution pCGDH.
본 발명에서 "프로모터"라는 용어는, 폴리머라아제에 대한 결합부위를 포함하고 프로모터 다운스트림 (downstream) 유전자의 mRNA로의 전사개시 활성을 갖는, 코딩 영역의 상위(upstream)의 비해독된 뉴클레오티드 서열을 의미한다. The term "promoter" in the present invention refers to a nucleotide sequence that is upstream of the coding region and contains a nucleotide sequence that is complementary to that of the coding region, including a binding site for a polymerase and having a transcription initiation activity into the mRNA of a promoter downstream gene it means.
또한, 본 발명에서 "작동 가능하게 연결된"이라는 용어는, 프로모터 활성을 갖는 핵산 서열이 ddh 유전자 및 다른 효소 등을 코딩하는 유전자의 전사 개시 및 프로모터 서열과 유전자 서열의 기능적 연결, 즉 발현이 필요한 유전자와 이의 조절 서열이 서로 기능적으로 결합되어 유전자 발현을 가능하게 하는 방식으로 연결되는 것을 의미한다.In addition, in the present invention, the term "operably linked" means that the transcriptional initiation of a gene whose promoter activity encodes a ddh gene and other enzymes, and the functional sequence of the promoter sequence and the gene sequence, that is, a gene requiring expression And its regulatory sequences are functionally linked to each other and linked in such a way as to enable gene expression.
또한, 본 발명에서 "상동성"이라는 용어는, 두 개의 폴리뉴클레오티드 사이의 동일성의 퍼센트를 의미하는 것으로서, 서열 정보를 정렬하고 용이하게 입수 가능한 컴퓨터 프로그램을 이용하여 두 개의 폴리펩티드 분자 간의 서열 정보를 직접 정렬함으로써 상동성을 결정할 수 있다. In the present invention, the term "homology" refers to a percentage of identity between two polynucleotides, wherein sequence information between two polypeptide molecules is directly measured using a computer program that aligns sequence information and is readily available. The homology can be determined by aligning.
또한, 본 발명에서 "벡터"라는 용어는, 적당한 숙주세포에서 목적 단백질을 발현할 수 있는 발현 벡터로서, 유전자 삽입물이 발현되도록 작동 가능하게 연결된 필수적인 조절요소를 포함하는 유전자 제조물을 뜻한다. 상기에서 "조절요소"는 전사를 수행하기 위한 프로모터, 전사를 조절하기 위한 임의의 오퍼레이터 서열, 적합한 mRNA 리보좀 결합 부위를 코딩하는 서열, 및 전사 및 해독의 종결을 조절하는 서열을 포함한다.Furthermore, the term "vector" in the present invention refers to an expression vector capable of expressing a desired protein in a suitable host cell, which gene construct contains an essential regulatory element operatively linked to the expression of the gene insert. As used herein, the term " regulatory element "includes promoters for performing transcription, any operator sequences for regulating transcription, sequences encoding suitable mRNA ribosome binding sites, and sequences controlling transcription and translation termination.
또한, 본 발명에서 "숙주세포"라는 용어는, 벡터가 숙주세포에 형질전환됨으로서 숙주세포 내에서 다양한 유전적 또는 분자적 영향을 미치게 되는 세포를 의미한다.In addition, in the present invention, the term "host cell" refers to a cell in which a vector is transformed into a host cell and thus has various genetic or molecular effects in the host cell.
또한, 본 발명에서 "형질전환"이라는 용어는, DNA를 숙주로 도입하여 DNA가 염색체외의 인자로서 또는 염색체로의 삽입에 의해 복제 가능하게 되는 것을 의미한다.In addition, the term "transformation" in the present invention means that the DNA is introduced into the host so that the DNA is replicable as an extrachromosomal factor or by insertion into the chromosome.
본 발명의 일 태양은, 서열번호 1, 서열번호 2, 서열번호 3 및 서열번호 4로 이루어진 군에서 선택되는 어느 하나 이상의 뉴클레오티드 서열을 포함하는, 코리네형 세균 유래 슈퍼옥사이드 디스뮤타제(SOD)를 코딩하는 유전자(sod 유전자)의 프로모터 변이체에 관한 것이다.One aspect of the present invention, Coryneform bacteria-derived superoxide dismutase (SOD) comprising any one or more nucleotide sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4 It relates to a promoter variant of the gene encoding (sod gene).
본 발명에 의한 상기 프로모터 변이체는 서열번호 1, 서열번호 2, 서열번호 3 및 서열번호 4로 이루어진 군에서 선택되는 어느 하나의 뉴클레오티드 서열로 구성되는 sod 유전자의 프로모터 변이체일 수 있다.The promoter variant according to the present invention may be a promoter variant of the sod gene consisting of any one of the nucleotide sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO:
원핵생물에서의 프로모터는 RNA 중합효소가 결합하는 전사시점 근처의 결합부위로 정의되며, 전사시작 지점으로부터 앞쪽으로 -10, -35 부위의 염기쌍이 떨어져 있는 두 개의 짧은 염기서열로 구성되어 있는데, 본 발명의 SOD 프로모터 변이체는 자연형 프로모터 (wild type)보다 높은 활성을 가지도록 개량된 것으로서, 상기 -35에서 -10 부위 안에서 변이시킴으로써 다운 스트림 유전자의 발현을 증가시킬 수 있다.The promoter in prokaryotes is defined as the binding site near the transcriptional site to which the RNA polymerase binds. The promoter is composed of two short base sequences spaced apart from the bases at -10 and -35 bases from the start of transcription. The SOD promoter variant of the present invention is improved to have higher activity than a wild-type promoter, and can mutate within the -35 to -10 region to increase the expression of the downstream gene.
상기 프로모터 변이체는 다운 스트림 목적 유전자의 발현 증가를 위하여, 그 유전자의 자연형 프로모터와 함께 사용될 수 있으며, 포함되는 서열의 길이 및 종류는 필요에 따라 조절될 수 있다. The promoter mutant may be used together with a naturally occurring promoter of the gene to increase the expression of a downstream target gene, and the length and type of the contained sequence may be adjusted as needed.
또한, 본 발명의 프로모터 변이체는 자연형 프로모터에 비해 활성이 증가된 프로모터 활성을 가짐으로써, 목적에 적합하게 프로모터의 기능을 개선시킬 수 있는데, 상기 변이는 다양한 방법에 의해 이루어질 수 있으며, 그 예는 부위-지정 돌연변이(site-directed mutagenesis), 에러유발 PCR(error-prone PCR), DNA 셔플링 방법((DNA shuffling) 등이 있다. In addition, the promoter variants of the present invention have improved promoter activity compared to the native promoter, thereby improving the function of the promoter to suit the purpose, the mutation can be made by a variety of methods, for example Site-directed mutagenesis, error-prone PCR, DNA shuffling methods (DNA shuffling), and the like.
보다 구체적인 양태로서, 본 발명에 따른 프로모터 변이체는, 서열번호 1, 서열번호 2, 서열번호 3 및 서열번호 4로 이루어진 군에서 선택되는 어느 하나 이상의 뉴클레오티드 서열을 포함하는 DNA 단편일 수 있다.In a more specific embodiment, the promoter variant according to the present invention may be a DNA fragment comprising any one or more nucleotide sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO:
보다 바람직하게는, 서열번호 1, 서열번호 2, 서열번호 3 및 서열번호 4로 이루어진 군에서 선택되는 어느 하나의 뉴클레오티드 서열로 구성되는 DNA 단편일 수 있다More preferably, it may be a DNA fragment consisting of any one of the nucleotide sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4
또한, 본 발명의 프로모터 변이체는 서열번호 1, 서열번호 2, 서열번호 3 또는 서열번호 4를 구성하는 하나 이상의 뉴클레오티드의 치환, 삽입 및 결실 변이체 및 이들의 조합을 포함할 수 있다. In addition, the promoter variants of the present invention may include substitution, insertion and deletion variants and combinations thereof of one or more nucleotides constituting SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 4.
상기 치환, 결실 또는 삽입의 임의의 조합은 구성요소의 기능이 온전히 동일하게 남아 있도록 유도될 수 있는데, 본 발명에 따른 프로모터 변이체는 DNA 단편이 상기 서열번호 1, 2, 3 또는 4로 표시되는 DNA 단편에 적어도 95% 이상의 상동성을 가지는 DNA 단편일 수 있다.Any combination of the substitutions, deletions or insertions may be induced so that the function of the components remains unchanged. The promoter variant according to the present invention is a DNA fragment in which the DNA fragment is the DNA represented by SEQ ID NO: 1, 2, 3 or 4 Or a DNA fragment having at least 95% or more homology to the fragment.
본 발명의 다른 태양은, 상기 프로모터 변이체를 포함하는 재조합 벡터에 관한 것이다.Another aspect of the invention relates to a recombinant vector comprising said promoter variant.
본 발명에 이용되는 벡터는 코리네형 세균 뿐만 아니라, 적합한 숙주세포 내로 형질전환된 후, 숙주세포의 게놈과 무관하게 복제 가능하거나 게놈 그 자체에 봉합될 수 있다. 이 때 상기 적합한 숙주세포는 벡터가 복제가능한 것으로서, 복제가 개시되는 특정 핵산서열인 복제 원점을 포함할 수 있다.The vectors used in the present invention can be transformed into suitable host cells as well as coryneform bacteria, and then can be replicated or sewn into the genome itself irrespective of the genome of the host cell. Wherein said suitable host cell is one in which the vector is replicable and may comprise a replication origin which is a specific nucleic acid sequence at which replication is initiated.
벡터로 사용되는 플라스미드는 숙주 내에 삽입 후에 선별될 수 있는 마커를 가지고 있으며, 바람직하게는 플라스미드 pK19mobsacB를 XbaI와 EcoRI 제한효소를 이용하여 절단한 뒤, 프로모터 돌연변이 서열을 삽입시켜 벡터를 제조할 수 있다. The plasmid used as the vector has a marker that can be selected after insertion into the host. Preferably, the plasmid pK19mobsacB is cleaved using XbaI and EcoRI restriction enzymes, and the vector can be prepared by inserting a promoter mutant sequence.
본 발명에 의한 벡터는 일반적 기능을 수행하도록 구조 유전자의 N-말단 서열의 서로 다른 변이체가 있는 부분을 포함하는 프로모터 변이체 핵산 서열과 목적하는 단백질을 코딩하는 뉴클레오티드 서열이 기능적으로 연결될 수 있는데, 상기 재조합 벡터와의 연결은 잘 알려진 기술분야로서, 유전자 재조합 기술을 이용하며, DNA절단 및 연결은 일반적으로 잘 알려진 효소 등을 사용할 수 있다. The vector according to the present invention may be functionally linked to a promoter mutant nucleic acid sequence comprising a portion having different variants of the N-terminal sequence of the structural gene and a nucleotide sequence encoding a protein of interest to perform a general function. Linkage with the vector is well known in the art, using genetic recombination technology, DNA cutting and linkage can be used generally known enzymes and the like.
또한, 본 발명에 의한 재조합 벡터는 선택 마커(selection marker)를 포함할 수 있는데, 상기 선택 마커는 벡터로 형질전환된 형질전환체를 선별하기 위한 것으로서, 상기 선택 마커가 처리된 배지에서 선택 마커를 발현하는 세포만 생존할 수 있기 때문에, 형질전환된 세포의 선별이 가능하다. 상기 선택 마커의 대표적인 예로서 카나마이신, 스트렙토마이신, 클로람페니콜 등이 있으며, 본 발명에서는 카나마이신을 사용할 수 있다.In addition, the recombinant vector according to the present invention may include a selection marker, which is used for screening a transformant transformed with a vector, wherein a selection marker is selected from the selection marker-treated medium Since only the expressing cells can survive, selection of transformed cells is possible. Representative examples of the selection marker include kanamycin, streptomycin, chloramphenicol, and the like, and kanamycin may be used in the present invention.
본 발명에 의한 재조합 벡터는 상기 프로모터 변이체가 목적 유전자의 코딩 서열과 작동 가능하게 연결된 것일 수 있는데, 상기 목적 유전자로는 디아미노피멜레이트 디하이드로게나제를 코딩하는 ddh 유전자, 아스파르토키나아제를 코딩하는 ask 유전자, 트랜스케톨라제를 코딩하는 tkt 유전자, 디하이드로피콜레이트 씬타아제를 코딩하는 dapA 유전자, 디하이드로피콜레이트 리덕타아제를 코딩하는 dapB 유전자, 디아미노피멜레이트 디카르복실라아제를 코딩하는 lysA 유전자, 아스파르트 세미알데하이드를 코딩하는 asd 유전자, 아스파테이트 트랜스아미나아제를 코딩하는 aspB 유전자, 글루코즈 6-포스페이트 디하이드로게나아제를 코딩하는 zwf 유전자, 포스페이트 글루코네이트 디하이드로게나아제를 코딩하는 gnd 유전자, 프럭토오즈 비스포스파타아제를 코딩하는 fbp 유전자, 피루베이트 카르복실라아제를 코딩하는 pycA 유전자로 이루어진 군에서 선택되는 1종 이상의 유전자를 포함할 수 있으나, 이에 한정되는 것은 아니다. The recombinant vector according to the present invention may be such that the promoter mutant is operably linked to the coding sequence of the gene of interest. As the gene of interest, the ddh gene coding for diaminopimelate dehydrogenase, aspartokinase, , The tkt gene encoding transketolase, the dapA gene coding for dihydropicolate synthase, the dapB gene coding for dihydropicolleyridylase, the aminopimelate decarboxylase coding gene an asd gene encoding an aspartate semialdehyde, an aspB gene encoding an aspartate transaminase, a zwf gene encoding a glucose 6-phosphate dehydrogenase, a gnd gene encoding a phosphate gluconate dehydrogenase, Fructose bisphosphatase May contain one or more kinds of genes selected from the group consisting of the fbp gene, the pyruvate kinase-carboxylic La encoding a pycA gene encoding, but is not limited to this.
상기 ddh 유전자의 뉴클레오타이드 서열은 Gene ID:3344238이고, ask 유전자의 뉴클레오타이드 서열은 Gene ID:3345161이며, tkt 유전자의 뉴클레오타이드 서열은 Gene ID:3343601이고, dapA 유전자의 뉴클레오타이드 서열은 Gene ID: 3345490이며, dapB 유전자의 뉴클레오타이드 서열은 Gene ID: 3345049이고, lysA 유전자의 뉴클레오타이드 서열은 Gene ID: 3344931이며, asd 유전자의 뉴클레오타이드 서열은 Gene ID: 3345564이며, aspB 유전자의 뉴클레오타이드 서열은 Gene ID: 3343262이고, zwf 유전자의 뉴클레오타이드 서열은 Gene ID: 3345621이며, gnd 유전자의 뉴클레오타이드 서열은 Gene ID: 3344993이고, fbp 유전자의 뉴클레오타이드 서열은 Gene ID: 3345276이며, pycA의 뉴클레오타이드 서열은 Gene ID: 3344537이다.Wherein the nucleotide sequence of the ddh gene is Gene ID: 3344238, the nucleotide sequence of the ask gene is Gene ID: 3345161, the nucleotide sequence of the tkt gene is Gene ID: 3343601, the nucleotide sequence of the dapA gene is Gene ID: 3345490, The nucleotide sequence of the asd gene is Gene ID: 3345564, the nucleotide sequence of the asdB gene is the Gene ID: 3343262, the nucleotide sequence of the zwf gene is the nucleotide sequence of the asp gene, The nucleotide sequence is Gene ID: 3345621, the nucleotide sequence of the gnd gene is Gene ID: 3344993, the nucleotide sequence of the fbp gene is Gene ID: 3345276, and the nucleotide sequence of pycA is Gene ID: 3344537.
본 발명의 또 다른 태양은, 상기 재조합 벡터로 형질전환된 숙주세포에 관한 것이다. Another aspect of the present invention relates to a host cell transformed with the recombinant vector.
본 발명에서 상기 숙주세포로는 코리네형 세균, 즉 코리네 박테리움 (Co-rynebacterium) 속 또는 브레비박테리움(Brevibacterium) 속의 균주, 특히 코리네박테리움 글루타미쿰, 보다 구체적으로는 코리네박테리움 글루타미쿰 ATCC 13032, 또는 상기 코리네박테리움 글루타미쿰 ATCC 13032 유래의 L-아미노산 생산 돌연변이체, 바람직하게는 코리네박테리움 글루타미쿰 KFCC10065일 수 있다. In the present invention, the host cell may be a coryneform bacterium, that is, a strain belonging to the genus Co-rynebacterium or Brevibacterium, in particular Corynebacterium glutamicum, An L-amino acid producing mutant derived from Corynebacterium glutamicum ATCC 13032, preferably Corynebacterium glutamicum ATCC 13032, or the above-mentioned Corynebacterium glutamicum ATCC 13032, preferably Corynebacterium glutamicum KFCC10065.
또한, 상기 숙주세포는 예를 들면, 상기 코리네박테리움 글루타미쿰과 다른 코리네박테리움속 균주인 코리네박테리움 써모아미노게네스(Corynebacterium thermoaminogenes), 브레비박테리움 플라붐(Brevibacterium flavum), 브레비박테리움 락토퍼멘툼(Brevibacterium lactofermentum), 및 이들로부터 제조된 L-아미노산 생산 돌연변이체일 수 있지만, 이에 한정되는 것은 아니다.In addition, the host cell is, for example, Corynebacterium glutamicum and other Corynebacterium strains Corynebacterium thermoaminogenes (Corynebacterium thermoaminogenes), Brevibacterium flavum (Brevibacterium flavum) , Brevibacterium lactofermentum, and L-amino acid producing mutants prepared therefrom, but are not limited thereto.
본 발명의 형질전환된 숙주세포는 상기 프로모터 변이체가 염색체내에 상동 재조합으로 삽입될 수 있다. 상동 재조합 방법으로는 유전자를 녹-아웃(knock-out)하거나 도입하는 유전학적 기법으로서, 상기 방법을 이용하여 변이된 프로모터 부위를 숙주세포에서 사용할 수 있게 제작된 것일 수 있다. 보다 구체적으로는 프로모터 활성을 증진시키도록 제작한 프로모터 변이체 서열을 ddh 유전자, ask 유전자, tkt 유전자 등과 같은 상기 코리네박테리움 글루타미쿰의 목적 유전자의 프로모터 부위를 상동 재조합의 방법으로 대체할 수 있다.In the transformed host cell of the present invention, the promoter variant may be inserted by homologous recombination in the chromosome. The homologous recombination method is a genetic technique that knocks out or introduces a gene. The homologous recombination method may be one designed to use a modified promoter region in a host cell. More specifically, the promoter mutant sequence prepared to enhance the promoter activity can be replaced with a promoter region of the target gene of Corynebacterium glutamicum such as ddh gene, ask gene, tkt gene, etc. by a homologous recombination method .
본 발명의 또 다른 태양은, 상기 형질전환된 숙주세포를 이용하여 배양하는 단계를 포함하는 아미노산의 생산방법에 관한 것이다.Another aspect of the invention relates to a method for producing an amino acid comprising culturing using the transformed host cell.
상기 아미노산으로는 L-라이신, L-트레오닌, L-메티오닌 등을 들 수 있으나, L-라이신이 바람직하다.Examples of the amino acid include L-lysine, L-threonine, and L-methionine, but L-lysine is preferable.
상기한 바와 같은 형질전환된 숙주세포(형질전환체)의 배양은 본 발명이 속하는 기술분야에서 공지된 통상적인 방법에 따라 실시될 수 있다. 이들 공지된 배양 방법은 문헌[Chmiel, (Bioprozesstechnik 1. Einfuhrung in die Bioverfahrenstechnik (Gustav Fischer Verlag, Stuttgart, 1991);및 Storhas (Bioreaktoren und periphere Einrichtungen (Vieweg Verlag, Braunschweig/Wiesbaden, 1994))에 기술되어 있다.Cultivation of the transformed host cell (transformant) as described above may be carried out according to conventional methods known in the art. These known culture methods are described in Chmiel, (
배양에 사용되는 배지는 적절한 방식으로 특정 균주의 요건을 충족해야 한다. 코리네박테리아 균주에 대한 배양배지는 공지되어 있다(예를 들면, Manual of Methods for General Bacteriology. American Society for Bacteriology. Washington D.C., USA, 1981). The medium used for the culture should meet the requirements of the particular strain in an appropriate manner. Culture media for Corynebacteria strains are known (eg, Manual of Methods for General Bacteriology. American Society for Bacteriology.Washington D.C., USA, 1981).
사용될 수 있는 당원으로는 글루코오스, 사카로오스, 락토오스, 프럭토오스, 말토오스, 전분, 셀룰로오스와 같은 당 및 탄수화물, 대두유, 해바라기유, 피마자유, 코코넛유 등과 같은 오일 및 지방, 팔미트산, 스테아린산, 리놀레산과 같은 지방산, 글리세롤, 에탄올과 같은 알코올, 아세트산과 같은 유기산이 포함된다. 이들 물질은 개별적으로 또는 혼합물로서 사용될 수 있다. 사용될 수 있는 질소원으로는 펩톤, 효모 추출물, 육즙, 맥아 추출물, 옥수수 침지액, 대두밀 및 요소 또는 무기 화합물, 예를 들면 황산암모늄, 염화암모늄, 인산암모늄, 탄산암모늄 및 질산암모늄이 포함된다. 질소원도 개별적으로 또는 혼합물로서 사용할 수 있다. Sugar sources that may be used include sugars and carbohydrates such as glucose, saccharose, lactose, fructose, maltose, starch and cellulose, oils and fats such as soybean oil, sunflower oil, castor oil, coconut oil, palmitic acid, stearic acid, linoleic acid , Alcohols such as glycerol, ethanol, and organic acids such as acetic acid. These materials may be used individually or as a mixture. Examples of nitrogen sources that may be used include peptone, yeast extract, gravy, malt extract, corn steep liquor, soybean wheat and urea or inorganic compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate. Nitrogen sources can also be used individually or as a mixture.
사용될 수 있는 인원으로는 인산이수소칼륨 또는 인산수소이칼륨 또는 상응하는 나트륨-함유 염이 포함된다. 또한, 배양배지는 성장에 필요한 황산마그네슘 또는 황산철과 같은 금속염을 함유할 수 있다. 또한, 상기 물질에 더하여 아미노산 및 비타민과 같은 필수 성장물질이 사용될 수 있다. 또한, 배양배지에 적절한 전구체들이 사용될 수 있다. 상기된 원료들은 배양과정에서 배양물에 적절한 방식에 의해 회분식으로 또는 연속식으로 첨가될 수 있다.Potassium which may be used include potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding sodium-containing salts. The culture medium may also contain metal salts such as magnesium sulfate or iron sulfate required for growth. In addition to the above substances, essential growth substances such as amino acids and vitamins may be used. In addition, precursors suitable for the culture medium may be used. The above-mentioned raw materials can be added to the culture in a batch manner or in a continuous manner by an appropriate method.
수산화나트륨, 수산화칼륨, 암모니아와 같은 기초 화합물 또는 인산 또는 황산과 같은 산 화합물을 적절한 방식으로 사용하여 배양물의 pH를 조절할 수 있다. 또한, 지방산 폴리글리콜 에스테르와 같은 소포제를 사용하여 기포 생성을 억제할 수 있다. 호기 상태를 유지하기 위해 배양물 내로 산소 또는 산소-함유 기체 (예, 공기)를 주입할 수 있다. Basic compounds such as sodium hydroxide, potassium hydroxide, ammonia, or acid compounds such as phosphoric acid or sulfuric acid can be used in a suitable manner to adjust the pH of the culture. In addition, bubble formation can be suppressed by using a defoaming agent such as a fatty acid polyglycol ester. Oxygen or an oxygen-containing gas (eg, air) may be injected into the culture to maintain aerobic conditions.
배양물의 온도는 보통 20℃ 내지 45℃, 바람직하게는 25℃ 내지 40℃이다. 배양은 원하는 표적 물질의 생성량이 최대로 얻어질 때까지 계속한다. 이러한 목적으로 보통 10 내지 160 시간에서 달성된다.The temperature of the culture is usually 20 ° C to 45 ° C, preferably 25 ° C to 40 ° C. Culture continues until the amount of target material desired is maximized. Usually for 10 to 160 hours for this purpose.
이하 본 발명을 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 실시하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to examples. However, these examples are for illustrative purposes only, and the scope of the present invention is not limited to these examples.
<< 실시예Example >>
본 실시예에서는 슈퍼옥사이드 디스뮤타아제(superoxide dismutases; SOD, EC 1.15.1.1)의 프로모터의 영역부위를 확인하기 위하여 프로모터 예측 프로그램을 사용하고, 다양한 sod 프로모터 변이체의 활성(strength)을 확인하기 위하여, L-라이신 합성에 관련된 유전자에 작동 가능하게 연결될 수 있는 형질전환체를 제작하였고, 코리네박테리아 클루타미쿰 균주에 상동 재조합을 통한 치환방법으로 개량 균주를 얻었다.
In the present embodiment, a promoter prediction program is used to identify regions of promoters of superoxide dismutases (SOD, EC 1.15.1.1), and to identify the activity of various sod promoter variants, A transformant that can be operably linked to a gene involved in L-lysine synthesis was prepared, and an improved strain was obtained by substitution method through homologous recombination to Corynebacterium glutamicum strain.
<< 실시예Example 1> 1> 코리네형Coryne type 세균 유래 Bacterial origin SODSOD 유전자의 프로모터 확보 및 염기서열 분석 Promoter of gene and nucleotide sequence analysis
1. One. sodsod 프로모터 영역 지정과 결정 Promoter designation and determination
본 실시예에서는 C. glutamicum ATCC 13032의 게놈 중, MsrA(EC.1.8.4.11) 유전자와 SodA (EC.1.15.1.1.) 유전자 사이의 부위를 정방향 프라이머(서열번호 5: 5'-GGGATCCTC GAAGGATC GTA AACAACCTCCAC-3'와 역방향 프라이머(서열번호 6: 5'-GGATCCTCCTTTCGTA GGTTTCCGCACC GAG-3'를 사용하여 PCR로 증폭시켜 pGEM-T 벡터 (Promega Corporation, Madison, WI. Cat. No. A1360) 내로 클로닝한 후, DNA 염기서열 분석을 실시하여 sod 유전자의 프로모터로 결정하였다. In this example, the region between the gene of MsrA (EC.1.8.4.11) and the gene of SodA (EC.1.15.1.1.) Among the genomes of C. glutamicum ATCC 13032 was designated as forward primer (SEQ ID NO: 5: 5'-GGGATCCTC GAAGGATC GTA (Promega Corporation, Madison, Wis. Cat. No. A1360) amplified by PCR using AACAACCTCCAC-3 'and a reverse primer (SEQ ID NO: 6: 5'-GGATCCTCCTTTCGTA GGTTTCCGCACC GAG-3' , DNA sequencing was performed to determine the promoter of sod gene.
SOD 프로모터에 해당하는 DNA 염기서열을 PROBABS와 PROMOSCAN 프로그램으로 컴퓨터 기반 분석(computer-based analysis)을 실시한 결과를 도 1의 SOD 프로모터의 영역으로 나타내었다.
The results of performing computer-based analysis of the DNA sequencing corresponding to the SOD promoter using PROBABS and the PROMOSCAN program are shown as regions of the SOD promoter of FIG. 1.
2. 2. sodsod 프로모터의 부위 지정과 전사시작 부위 확인 Designation of promoter site and transcription start site
코리네박테리움 글루타미쿰(C. glutamicum ) SOD 유전자 발현에 관여하는 프로모터 부위를 computer-aided program 을 통해 putative -10과 -35 부위가 확인되었다. Corynebacterium glutamicum (C. glutamicum) the putative -10 and -35 regions were identified the promoter region involved in the SOD gene expression through computer-aided program.
상기 프로모터의 전사시작 부위를 확인하기 위하여, C. glutamicum ATCC 13032로부터 Trizol™ 용액(Invitrogen사)을 시약 제조사의 방법에 따라 total RNA를 분리하였다. 다만 상기 Trizol™ 처리시 글래스 비드 (≥100㎛)를 가하여 4℃에서 3초 on/5초 off 조건으로 비드 비터(bead beatter)로 3회 처리하여 세포 용해를 유도하였다. 이때 5'-Full RACE PCR에 사용한 프라이머와 각 프라이머의 뉴클레오타이드 서열을 사용하였다. Total RNA was isolated from C. glutamicum ATCC 13032 by Trizol (TM) solution (Invitrogen) according to the manufacturer's method to identify the transcription initiation site of the promoter. However, in the above Trizol (TM) treatment, glass beads (? 100 占 퐉) were added and treated with bead beater 3 times at 4 占 폚 for 3 seconds on / 5 seconds off to induce cell lysis. At this time, the primer used for the 5'-Full RACE PCR and the nucleotide sequence of each primer were used.
간략히 설명하면, 분리한 세균 RNA에 C. glutamicum SOD 특이 프라이머 (RI)를 이용하면 먼저 1st cDNA를 역전사 효소로 37℃에서 1시간 반응시킨 후, 75℃에서 5분간 열처리하였다. Briefly, using the C. glutamicum SOD specific primer (RI) on the isolated bacterial RNA, 1 st The cDNA was reacted with reverse transcriptase at 37 ° C for 1 hour and then heat-treated at 75 ° C for 5 minutes.
다음에 주형 RNA를 RNase 처리로 분해하였다. 이를 주형으로 하여 제작한 프라이머 세트로 SOD 의 비번역 부위(untranslated region)를 PCR로 증폭한 다음 클로닝한 후, DNA 서열분석을 통하여 SOD 유전자의 전사개시 부위를 최종 확인하였다.
The template RNA was then digested with RNase treatment. The untranslated region of SOD was amplified by PCR with a primer set prepared as a template, and then cloned and finally confirmed the transcription initiation site of the SOD gene through DNA sequence analysis.
<< 실시예Example 2> 변이 프로모터 삽입용 재조합 벡터의 제작 2> Construction of Recombinant Vector for Mutation Promoter Insertion
프로모터 야생형 프로모터는 C. glutamicum ATCC13032 균주를 주형으로 히여 SOD 프로모터 부위로 인식되어진 약 300 bp의 크기를 사용하였고, SOD의 프로모터 변이체는 이미 Bioneer사에 의해 합성되어진 플라스미드를 주형으로 하여 하기 표 1의 pCGDH 정방향 프라이머(서열번호 7) 및 pCGDH 역방향 프라이머(서열번호 8)로 PCR을 수행하여 단편을 수득하였다. The promoter wild type promoter was obtained by digesting the C. glutamicum ATCC13032 strain as a template with a size of about 300 bp recognized as a SOD promoter site. The promoter mutant of SOD was transformed with the plasmid pCGDH PCR was performed with a forward primer (SEQ ID NO: 7) and a pCGDH reverse primer (SEQ ID NO: 8) to obtain a fragment.
상기 프로모터에 작동 가능하게 디아미노피멀레이트 디하이드로게나아제를 코딩하는 유전자(ddh 유전자)를 연결하고, 오버랩 PCR을 수행하여 PCR 단편을 수득하였다. A DNA fragment (ddh gene) encoding diaminopimelate dehydrogenase was operatively linked to the promoter, and overlap PCR was performed to obtain a PCR fragment.
클로닝 작업을 위하여 XbaI과 EcoRI으로 제한효소 처리하였고, pK19mobsacB 벡터Schafer A, et al. 1994 Gene 145: 69-73)에 동일한 XbaI과 EcoRI을 이용하여 제한효소로 소화시켜 PCR 정제 키트(퀴아젠 (Qiagen), Hilden, Germany)로 정제한 후 T4 DNA 리가제를 이용하여 클로닝하고, E. coli DH5a (RBC Bioscience, Taiwan Cat. No. RH618. Hanahan, D. 1983 J . Mol. Biol. 166:557-580) 에 형질전환시켰다. For cloning, restriction enzymes were treated with XbaI and EcoRI, and the pK19mobsacB vectorSchafer A, et al. 1994 Gene 145: same XbaI and EcoRI, using a PCR purification kit was digested with restriction enzymes to 69-73) (Qiagen (Qiagen), Hilden, Germany was purified by) T4 DNA Riga cloned using the agent, and E . coli DH5a: was transformed to (... RBC Bioscience, Taiwan Cat No. RH618 Hanahan, D. 1983 J Mol Biol 166.. 557-580).
플라스미드 함유 세포의 선택은 카나마이신 (50㎍/ml)이 포함되어진 LB (Luria-Bertani) 아가 플레이트에 도말하고, 37℃에서 16시간 정치하였다. 생성된 콜로니들의 플라스미드 확인은 plasmid miniprep kit (Qiagen, Hilden, Germany)를 이용하여 추출하였고, 클로닝에 사용되어진 XbaI 및 EcoRI 제한 효소로 처리하여 유전자의 단편을 확인하고 최종 그 유전자의 염기서열 분석을 확인하였다. The selection of plasmid-containing cells was plated on LB (Luria-Bertani) agar plates containing kanamycin (50 μg / ml) and left at 37 ° C. for 16 hours. Plasmid identification of the resulting colonies was performed using a plasmid miniprep kit (Qiagen, Hilden, Germany), and XbaI and EcoRI restriction enzymes used for cloning were used to identify the gene fragments. Respectively.
이렇게 생성된 플라스미드는 "pCGDH"라고 명명하였다(서열번호 1). 상기 pCGDH을 주형으로 다양한 sod 프로모터 변이체를 위한 프라이머를 이용하여 Quick-change site directed mutagenesis kit (Stratagene, La Jolla, CA) 시스템으로 변이 도입을 수행하였다. The resulting plasmid was named "pCGDH" (SEQ ID NO: 1). The pCGDH was used as a template and a mutagen was introduced into a Quick-change site directed mutagenesis kit (Stratagene, La Jolla, Calif.) Using primers for various sod promoter mutants.
상기 sod 프로모터 변이체를 위한 프라이머는 하기 표 1에서 보는 바와 같이, SDm1은 서열번호 9, 10을, SDm2는 서열번호 11, 12를 각각 사용하였으며, SDm3는 서열번호 13, 14를 사용하였다. As the primers for the sod promoter mutants, SDm1 used SEQ ID NOs: 9 and 10, SDm2 used SEQ ID NOs: 11 and 12, and SDm3 used SEQ ID NOs: 13 and 14, respectively, as shown in Table 1 below.
각 프라이머 125 ng을 사용하고, PfuUltra DNA 중합효소를 첨가하여 95℃에서 1분 동안 예열 단계를 거친 후, 18 사이클을 수행하였다. 각 사이클은 95℃에서 50초 동안 변성, 60℃에서 50초 동안 풀림, 68℃에서 약 4분 동안 신장 단계로 이루어지고, 마지막 사이클은 68℃에서 7분간 신장 단계를 수행하였다. 125 ng of each primer was used and PfuUltra DNA polymerase was added, followed by preheating at 95 ° C for 1 minute and then 18 cycles. Each cycle consisted of denaturation at 95 캜 for 50 seconds, annealing at 60 캜 for 50 seconds, extension at 68 캜 for about 4 minutes, and a final cycle at 68 캜 for 7 minutes.
PCR을 수행하고 DpnI 효소처리 후, XL10-Gold 대장균 세포에 형질전환시킨 다음, 카나마이신 (50㎍/ml)이 포함되어진 LB (Luria-Bertani) 아가 플레이트에 도말하여 37℃에서 16시간 정치하여 얻어진 sod 프로모터 변이 클론들을 각각 "SDm1", "SDm2" 및 "SDm3"라고 명명하였다. 선택된 콜로니들의 변이발생 유무는 최종 DNA 시퀀싱을 통하여 확인하였다. Sod obtained by PCR and DpnI enzyme treatment, transformed into XL10-Gold Escherichia coli cells, and then plated on LB (Luria-Bertani) agar plate containing kanamycin (50 µg / ml) and standing at 37 ° C for 16 hours. Promoter variant clones were named "SDm1", "SDm2" and "SDm3", respectively. The presence or absence of mutation of the selected colonies was confirmed by the final DNA sequencing.
<실시예 3> 코리네박테리움 글루타미쿰 균주 내로의 삽입 및 효소활성 측정 Example 3 Corynebacterium Insertion and Enzyme Activity Measurement into Glutamicum Strain
본 실시예에서는 코리네박테리움의 프로모터 변이체가 삽입되어 있는 상기 기 벡터를 이용하여 코리네박테리움 글루타미쿰을 형질전환시키고 상동 재조합을 통해 치환시킴으로써, 변이 유전자를 삽입시켰다.
In this Example, the mutant gene was inserted by transforming Corynebacterium glutamicum with homologous recombination using the above-mentioned group vector in which a promoter mutant of Corynebacterium was inserted.
1. 형질 전환1. Transformation
상기 pK19mobsacB 벡터에 프로모터 변이 도입이 확인된 클론을 C. glutamicum에 형질전환하기 위하여 C. glutamicum KFCC10065를 수용성 세포(competent cell)로 제작하였다. C. glutamicum KFCC10065 was transformed into competent cells to transform the clone in which the promoter mutation was confirmed in the pK19mobsacB vector into C. glutamicum .
10ml CM-broth 배지[포도당 10 g, 폴리펩톤 10 g, 효모추출물 5 g, NaCl 2.5 g, Urea 2 g (증류수 1리터 기준), pH 7.0]에서 30℃의 온도로 밤새 배양하였다. 상기 전배양된 세포는 100ml의 BHIS 배지[BHI 37 g, 2M 소르비톨 250ml (증류수 1L 기준)]에 OD(600nm)가 0.2-0.3이 되도록 접종하여 30℃에서 200 rpm으로 OD(600nm)가 0.8-0.9이 될 때까지 6시간 동안 배양하였다. Incubated overnight at 30 ° C. in 10 ml CM-broth medium [10 g of glucose, 10 g of polypeptone, 5 g of yeast extract, 2.5 g of NaCl, 2 g of Urea (based on 1 liter of distilled water), pH 7.0]. The pre-cultured cells were inoculated in 100 ml of BHIS medium (37 g of BHI, 250 ml of 2 M sorbitol (based on 1 L of distilled water)) to an OD (600 nm) of 0.2-0.3, and the OD (600 nm) And incubated for 6 hours until it reached 0.9.
배양액은 전처리된 튜브(prechilled tube)에 넣고 4℃에서 5000 rpm에 3-4번 10% 글리세롤로 반복적으로 세정하여 세포를 회수하고, 이 세포는 10% 글리세롤로 현탁시켜 100 ㎕씩 분주하여 -70℃에서 보관하면서 사용하였다. The culture solution was placed in a prechilled tube and washed repeatedly with 10% glycerol 3-4 times at 5000 rpm at 4 ° C. to recover the cells. The cells were suspended in 10% glycerol and divided into 100 μl. Used while storing at ℃.
상기 수용성 세포를 이용하여 제작된 구축물을 electorporation 0.2cm cuvette을 이용하여 BIO-RAD사의 펄서(2.5kv, 25 ㎌, 200Ω)로 형질전환시켰다. 그 후, CM-broth 배지 1ml을 첨가한 후에 바로 46℃에서 6분 동안 예열(pre-warmming)하고 200 rpm , 30℃에서 2 시간 동안 진탕배양을 한 후, 카나마이신 (25㎍/ml)이 포함되어진 BHIS (Brain Heart Infusion) 아가 플레이트에 도말하고, 30℃에서 32시간 동안 정치하였다. The constructs constructed using the water-soluble cells were transformed into a pulsar (2.5 kv, 25 ㎌, 200 Ω) of BIO-RAD using an electroporation 0.2 cm cuvette. Thereafter, 1 ml of CM-broth medium was added, followed by pre-warming at 46 ° C for 6 minutes, shaking culture at 200 rpm and 30 ° C for 2 hours, and then adding kanamycin (25 μg / ml) (Brain Heart Infusion) agar plate, and allowed to stand at 30 DEG C for 32 hours.
상기 생성된 콜로니들은 2차 재조합에 이용하기 위해 200 ㎕ BHIS 배지에 접종하고 30℃에서 200rpm으로 밤새 배양하고, 그 배양액을 1:1000으로 희석하여 10% 수크로오즈 (Jager, et al., 1992. J Bacteriol. 174:5462)가 포함된 CM 아가 플레이트에 도말하고, 30℃에서 72시간 동안 정치한 후 생성된 콜로니를 다시 카나마이신의 내성이 없는지 확인한 후, PCR로 확인하고 DNA 시퀀싱으로 최종 확인하였다.
The resulting colonies were inoculated into 200 μl of BHIS medium for use in secondary recombination, cultured overnight at 30 ° C. and 200 rpm, diluted to 1: 1000 with 10% sucrose (Jager, et al., 1992 . J Bacteriol. 174: 5462), and incubated at 30 ° C for 72 hours. After the colonies were confirmed to be resistant to kanamycin, they were confirmed by PCR and finally confirmed by DNA sequencing .
2. 효소활성 측정2. Enzyme activity measurement
선별된 콜로니들을 활성화시켜 10ml CM 배지에 1 루프 접종하여 30℃, 16 시간, 180 rpm의 조건으로 진탕 배양하였다. 10ml CM 배지에서 진탕된 세포 1 ml을 접종하고 30℃, 180 rpm에서 96시간 동안 진탕배양하였다.The selected colonies were activated and inoculated one loop to 10 ml of CM medium and incubated at 30 ° C for 16 hours with shaking at 180 rpm. 1 ml of shaken cells was inoculated in 10 ml of CM medium and cultured with shaking at 30 DEG C and 180 rpm for 96 hours.
배양된 세포를 원심분리 (3,660g, 15분, 4℃)를 통하여 균체를 수거하고 50 mM 인산칼륨 버퍼 (pH 7.5) 5 ml로 3회 세척한 후, 동일한 버퍼를 사용하여 2.5 ml로 재현탁하고, 현탁액 1㎖당 1.25g의 글래스 비드를 넣어 비드 비터(mini-beadbeater, Biospec Products, OK,USA)를 30초씩 이용하고, 얼음에 3분 동안 정치시키는 과정을 10회 반복하여 균체를 파쇄하였다.The cultured cells were harvested by centrifugation (3,660 g, 15 min, 4 ° C), washed three times with 5 ml of 50 mM potassium phosphate buffer (pH 7.5), resuspended to 2.5 ml using the same buffer , And the procedure of placing 1.25 g of glass beads per 1 ml of the suspension and using a mini-beadbeater (Biospec Products, OK, USA) for 30 seconds and allowing to stand for 3 minutes on ice was repeated 10 times to disrupt the cells .
원심분리(10,000g, 30분, 4℃)를 통하여 상층액을 수거하고 브래드 포드 방법(Anal. Biochem. 1976. 72:248-254, BIO-RAD LABORATORIES. 1985)을 이용하여 단백질을 정량한 후, 디아미노피멜레이트 디하이드로게나제 (ddh) 효소활성을 측정하기 위하여 조단백질 용액으로 사용하였다. 상기 효소활성의 측정은 0.2 M Glycine/NaOH (pH 10.5), 2 mM NADP, 4 mM 메조디아미 노피멜레이트(meso-DAP)를 포함하고 있는 반응액과 약 0.01 ml의 조단백질 용액을 혼합하여 총 부피가 1ml이 되도록 하여 반응을 개시한 후, 상온에서 5분간 반응시키고 340 nm 파장에서 흡광도를 측정하였다. 이때 디아미노피멜레이트 디하이드로게나제 효소활성 단위는 1분간 1 mg의 단백질이 환원시킨 NADPH mmole로 정의하였다. The supernatant was collected through centrifugation (10,000 g, 30 min, 4 ° C) and proteins were quantified using the Bradford method (Anal. Biochem. 1976. 72: 248-254, BIO-RAD LABORATORIES. , Diaminopimelate dehydrogenase (ddh) enzyme activity was used as crude protein solution. The enzyme activity was measured by mixing a reaction solution containing 0.2 M Glycine / NaOH (pH 10.5), 2 mM NADP, and 4 mM mesodiami nopimelate (meso-DAP) with about 0.01 ml of crude protein solution. After the reaction was initiated with a volume of 1 ml, the reaction was carried out at room temperature for 5 minutes and the absorbance was measured at a wavelength of 340 nm. At this time, diaminopimelate dehydrogenase enzyme activity unit was defined as NADPH mmole reduced by 1 mg of protein for 1 minute.
측정 결과, 하기 표 2에서 보는 바와 같이, 코리네박테움 글루타미쿰 10065-SDm2는 코리네박테움 글루타미쿰 10065-SDwt(야생형 sod 프로모터를 삽입한 균주)보다 약 2.5배 증가된 것이 확인되었다. 또한 코리네박테움 글루타미쿰 10065-SDm1은 코리네박테움 글루타미쿰 10065-SDwt보다 1.5 배가 증가되었고 코리네박테움 글루타미쿰 10065-SDm3은 코리네박테움 글루타미쿰 10065-SDwt보다는 1.7배 증가된 것이 확인되었다.As a result of the measurement, it was confirmed that Corynebacterium glutamicum 10065-SDm2 was increased about 2.5 times as compared with Corynebacterium glutamicum 10065-SDwt (strain in which the wild type sod promoter was inserted) as shown in Table 2 below. In addition, Corynebacterium glutamicum 10065-SDm1 was 1.5-fold more potent than Corynebacterium glutamicum 10065-SDwt and Corynebacterium glutamicum 10065-SDm3 was 1.7-fold more potent than Corynebacterium glutamicum 10065-SDwt .
< < 실시예Example 4> 형질전환된 숙주세포를 이용한 L-라이신 생산 4> Production of L-lysine using transformed host cells
코리네박테리움 글루타미쿰 10065 균주 및 실시예3 에서 제조한 프로모터 변이체로 형질전환된 개량 균주의 L-라이신 생산을 위해 아래와 같이 배양하였다.Corynebacterium glutamicum 10065 strain and the modified strain transformed with the promoter mutant prepared in Example 3 were cultured as follows for the production of L-lysine.
CM 배지[포도당 10 g, 폴리펩톤 10 g, 효모추출물 5 g, NaCl 2.5 g, Urea 2 g (증류수 1리터 기준), pH 7.0]를 10 ml 함유한 100ml 플라스크에 모균주인 코리네박테리움 글루타미쿰 10065와 코리네박테리움 글루타미쿰 SDm1, 코리네박테리움 글루타미쿰 SDm2, 및 코리네박테리움 글루타미쿰 SDm3 균주를 각각 접종하고, 30℃에서 16시간, 180 rpm의 조건으로 진탕배양하였다. In a 100 ml flask containing 10 ml of CM medium [10 g of glucose, 10 g of polypeptone, 5 g of yeast extract, 2.5 g of NaCl, 2 g of Urea (based on 1 liter of distilled water), pH 7.0], 10 ml of the mother strain Corynebacterium glue Corynebacterium glutamicum SDm1, Corynebacterium glutamicum SDm2, and Corynebacterium glutamicum SDm3 were inoculated, respectively, and cultured at 30 DEG C for 16 hours at 180 rpm in a shaking culture Respectively.
100 ml 플라스크에 하기의 L-라이신 배지를 10 ml 첨가하여 CM 배지에서 진탕 배양된 세포 1 ml을 접종하고, 30℃, 180 rpm, 96시간의 조건으로 진탕 배양하였다. 배양 종료 후 L-라이신의 생산량을 측정은 RI 디텍터를 이용하여 HPLC (LC-20AD Shimazu, Japan) (Hill DW et al., 1979. Anal Chem 51:1338)로 분석하였다. 컬럼은 Ionospher 5C column (100×3.0 mm; Chrompack, Engstingen, Germany)으로 40℃에서 분석하였고 측정결과를 표 3에 나타내었다.10 ml of the following L-lysine medium was added to a 100 ml flask to inoculate 1 ml of shake-cultured cells in CM medium, and shake culture was performed at 30 ° C, 180 rpm, and 96 hours. The amount of L-lysine produced after the completion of the culture was analyzed by HPLC (LC-20AD Shimazu, Japan) (Hill DW et al., 1979. Anal Chem 51: 1338) using an RI detector. The column was analyzed with an Ionospher 5C column (100 × 3.0 mm; Chrompack, Engstingen, Germany) at 40 ° C. The measurement results are shown in Table 3.
하기 표 3과 같은 결과에 의해, ddh 활성이 강하게 나타난 코리네박테리움 글루타미쿰 SDm2의 L-라이신 생산량이 모균주보다 10.3% 증가된 것을 알 수 있었고, 야생형 sod 프로모터 균주(코리네박테움 글루타미쿰 10065-SDwt) 보다는 7.2% 증가된 것을 확인하였다 As a result of Table 3, it was found that L-lysine production of Corynebacterium glutamicum SDm2, which exhibited strong ddh activity, was increased by 10.3% compared to the parent strain, and the wild-type sod promoter strain (Corynebacterium glutami) Qum 10065-SDwt) was found to increase 7.2%
또한, 코리네박테리움 글루타미쿰 SDm1와 코리네박테리움 글루타미쿰 SDm2은 10065-SDwt(야생형 sod 프로모터를 삽입한 균주)보다 4.7% 증가되었고, SDm1과 SDm3은 10065-SDwt 균주보다는 각각 2.2% 및 2.8% 증가된 것을 알 수 있었다.
In addition, Corynebacterium glutamicum SDm1 and Corynebacterium glutamicum SDm2 were 4.7% higher than 10065-SDwt (strain inserted with wild type sod promoter), and SDm1 and SDm3 were 2.2% higher than 10065-SDwt strains, respectively. And 2.8% increase.
[L-라이신 배지 조성 (pH 7. 0)][L-lysine medium composition (pH 7.0)]
당밀 16g, 원당 51g, (NH4)2SO4 30g, KH2PO4 1g, MgSO4-7H2O 1g, FeSO4-7H2O 10mg, MnSO4-5H2O 10mg, Thiamine 1mg, Biotin 1mg, CaCO3 5% (증류수 1L 기준)Molasses 16g, Raw Sugar 51g, (NH 4 ) 2 SO 4 30g, KH 2 PO 4 1g, MgSO 4 -7H 2 O 1g, FeSO 4 -7H 2 O 10mg, MnSO 4 -5H 2 O 10mg, Thiamine 1mg, Biotin 1mg , CaCO 3 5% (based on 1L of distilled water)
상술한 바와 같이, 본 발명의 바람직한 실시예를 참조하여 설명하였지만 해당 기술 분야의 숙련된 통상의 기술자라면 하기의 특허청구범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다. While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art in light of the above teachings. It will be understood that the invention may be varied and varied without departing from the scope of the invention.
본 발명에 의한 코리네형 세균 유래 sod 유전자의 프로모터 변이체는, 디아미노피멜레이트 디하이드로게나제를 코딩하는 유전자(ddh 유전자), 아스파르토키나아제를 코딩하는 유전자(ask 유전자), 트랜스케톨라제를 코딩하는 유전자(tkt 유전자), 디하이드로피콜레이트 씬타아제를 코딩하는 유전자(dapA 유전자), 디하이드로피콜레이트 리덕타아제를 코딩하는 유전자(dapB 유전자), 디아미노피멜레이트 디카르복실라아제를 코딩하는 유전자(lysA 유전자), 아스파르트 세미알데하이드를 코딩하는 유전자(asd 유전자), 아스파테이트 트랜스아미나아제를 코딩하는 유전자(aspB 유전자), 글루코즈 6-포스페이트 디하이드로게나아제를 코딩하는 유전자(zwf 유전자), 포스페이트 글루코네이트 디하이드로게나아제를 코딩하는 유전자(gnd 유전자), 프럭토오즈 비스포스파타아제를 코딩하는 유전자(fbp 유전자), 피루베이트 카르복실라아제를 코딩하는 유전자(pycA 유전자)로 이루어진 군에서 선택되는 1종 이상인 목적 유전자의 코딩 서열과 작동 가능하게 연결됨으로써, 발현되는 효소의 활성이 증가될 수 있다. The promoter mutant of the sod gene derived from a coryneform bacterium according to the present invention is a gene encoding a diaminopimelate dehydrogenase (ddh gene), a gene encoding an aspartokinase (ask gene), a transketolase coding (DapA gene) encoding a dihydropicolate synthase, a gene (dapB gene) encoding a dihydropicolinate dehydrogenase, a gene encoding a diaminopimelate decarboxylase (Asd gene) encoding an aspartate transaminase (aspB gene), a gene encoding a glucose 6-phosphate dehydrogenase (zwf gene), a gene coding for an aspartate transaminase A gene coding for gluconate dehydrogenase (gnd gene), a fructose bspspar The activity of an enzyme expressed by being operably linked with a coding sequence of one or more genes of interest selected from the group consisting of an enzyme coding gene (fbp gene) and a pyruvate carboxylase gene (pycA gene) This can be increased.
또한, 본 발명은 상기 sod 유전자의 프로모터 변이체가 삽입된 숙주세포를 이용하여, 모균주보다 L-라이신과 같은 아미노산의 생합성을 과발현시킴으로써, L-라이신과 같은 아미노산 발효생산 균주개발에 유용하게 사용될 수 있다.In addition, the present invention overexpresses biosynthesis of an amino acid such as L-lysine by using a host cell into which a promoter mutant of the sod gene is inserted, thereby being useful for the development of an amino acid fermentation-producing strain such as L-lysine have.
<110> PAIK KWANG INDUSTRIAL CO., Ltd; Kyungpook National University <120> Promoter variant of sod gene derived from coryneform bacteria and method for producing L-lysine using the promoter variant <160> 14 <170> KopatentIn 1.71 <210> 1 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promotersequesnce(pCGI) <400> 1 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaattt cgttgcaata 180 tcaacaaaaa ggcctatcat tgggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 2 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter variant(SDm1) <400> 2 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaatcc cgttgcaata 180 tcaacaaaaa ggcctatcat tgggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 3 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter variant(SDm2) <400> 3 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaattt cgttgcaata 180 tcaacaaaaa ggtgtataat ggggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 4 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter(SDm3) <400> 4 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaatcc cgttgcaata 180 tcaacaaaaa ggtgtacaat tgggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 5 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 5 gggatcctcg aaggatcgta aacaacctcc ac 32 <210> 6 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 6 ggatcctcct ttcgtaggtt tccgcaccga g 31 <210> 7 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 7 cgtctagact gcagctttaa gcgcctcatc agcgg 35 <210> 8 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 8 cgcgaattct tgcttcgtcg atgaagttga c 31 <210> 9 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 9 taggtcggct gaaaaatccc gttgcaatat caacaa 36 <210> 10 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 10 ttgttgatat tgcaacggga tttttcagcc gaccta 36 <210> 11 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 11 atcaacaaaa aggtgtataa tggggaggtg tcgca 35 <210> 12 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 12 tgcgacacct ccccattata cacctttttg ttgat 35 <210> 13 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 13 atatcaacaa aaaggtgtac aattgggagg tgtcgc 36 <210> 14 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 14 gcgacacctc ccaattgtac acctttttgt tgatat 36 <110> PAIK KWANG INDUSTRIAL CO., Ltd .; Kyungpook National University <120> Promoter variant of sod gene derived from coryneform bacteria and method for producing L-lysine using the promoter variant <160> 14 <170> Kopatentin 1.71 <210> 1 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter sequence (pCGI) <400> 1 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaattt cgttgcaata 180 tcaacaaaaa ggcctatcat tgggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 2 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter variant (SDm1) <400> 2 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaatcc cgttgcaata 180 tcaacaaaaa ggcctatcat tgggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 3 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter variant (SDm2) <400> 3 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaattt cgttgcaata 180 tcaacaaaaa ggtgtataat ggggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 4 <211> 300 <212> DNA <213> Artificial Sequence <220> <223> SOD promoter (SDm3) <400> 4 aagcgcctca tcagcggtaa ccatcacggg ttcgggtgcg aaaaaccatg ccataacagg 60 aatgttcctt tcgaaaattg aggaagcctt atgcccttca accctactta gctgccaatt 120 attccgggct tgtgacccgc tacccgataa ataggtcggc tgaaaaatcc cgttgcaata 180 tcaacaaaaa ggtgtacaat tgggaggtgt cgcaccaagt acttttgcga agcgccatct 240 gacggatttt caaaagatgt atatgctcgg tgcggaaacc tacgaaagga ttttttaccc 300 300 <210> 5 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 5 gggatcctcg aaggatcgta aacaacctcc ac 32 <210> 6 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 6 ggatcctcct ttcgtaggtt tccgcaccga g 31 <210> 7 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 7 cgtctagact gcagctttaa gcgcctcatc agcgg 35 <210> 8 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 8 cgcgaattct tgcttcgtcg atgaagttga c 31 <210> 9 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 9 taggtcggct gaaaaatccc gttgcaatat caacaa 36 <210> 10 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 10 ttgttgatat tgcaacggga tttttcagcc gaccta 36 <210> 11 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 11 atcaacaaaa aggtgtataa tggggaggtg tcgca 35 <210> 12 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 12 tgcgacacct ccccattata cacctttttg ttgat 35 <210> 13 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 13 atatcaacaa aaaggtgtac aattgggagg tgtcgc 36 <210> 14 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 14 gcgacacctc ccaattgtac acctttttgt tgatat 36
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120054145A KR101492134B1 (en) | 2012-05-22 | 2012-05-22 | Promoter variant of sod gene derived from coryneform bacteria and method for producing L-lysine using the promoter variant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120054145A KR101492134B1 (en) | 2012-05-22 | 2012-05-22 | Promoter variant of sod gene derived from coryneform bacteria and method for producing L-lysine using the promoter variant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20130130377A true KR20130130377A (en) | 2013-12-02 |
| KR101492134B1 KR101492134B1 (en) | 2015-02-12 |
Family
ID=49980064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR20120054145A Active KR101492134B1 (en) | 2012-05-22 | 2012-05-22 | Promoter variant of sod gene derived from coryneform bacteria and method for producing L-lysine using the promoter variant |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101492134B1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017034165A1 (en) * | 2015-08-27 | 2017-03-02 | 씨제이제일제당(주) | Corynebacterium sp. microorganisms having l-lysine-producing ability and method for producing l-lysine using same |
| JP2017531437A (en) * | 2014-10-30 | 2017-10-26 | サムヤン コーポレイション | Psicose epimerase expression system and production of psicose using the system |
| WO2019190192A1 (en) * | 2018-03-27 | 2019-10-03 | 씨제이제일제당 (주) | Novel promoter, and method for producing l-amino acid by using same |
| CN115044490A (en) * | 2021-03-09 | 2022-09-13 | 大象株式会社 | Corynebacterium glutamicum mutant strain having improved L-lysine productivity and method for producing L-lysine using the same |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025165041A1 (en) * | 2024-01-29 | 2025-08-07 | 연세대학교 산학협력단 | Heterologous promoter for high-level protein expression in corynebacterium glutamicum and use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008126896A1 (en) | 2007-04-10 | 2008-10-23 | Ajinomoto Co., Inc. | Method for production of organic acid |
-
2012
- 2012-05-22 KR KR20120054145A patent/KR101492134B1/en active Active
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11111485B2 (en) | 2014-10-30 | 2021-09-07 | Samyang Corporation | Expression system for Psicose epimerase and production for Psicose using the same |
| JP2017531437A (en) * | 2014-10-30 | 2017-10-26 | サムヤン コーポレイション | Psicose epimerase expression system and production of psicose using the system |
| US10240140B2 (en) | 2014-10-30 | 2019-03-26 | Samyang Corporation | Expression system for psicose epimerase and production for psicose using the same |
| US11168317B2 (en) | 2014-10-30 | 2021-11-09 | Samyang Corporation | Expression system for psicose epimerase and production for psicose using the same |
| RU2687206C1 (en) * | 2015-08-27 | 2019-05-07 | СиДжей ЧЕИЛДЗЕДАНГ КОРПОРЕЙШН | Microorganisms of corynebacterium sp., capable of producing l-lysine, and a method for producing l-lysine using said microorganisms |
| US10703783B2 (en) | 2015-08-27 | 2020-07-07 | Cj Cheiljedang Corporation | Corynebacterium sp. microorganisms having L-lysine-producing ability and method for producing L-lysine using same |
| WO2017034165A1 (en) * | 2015-08-27 | 2017-03-02 | 씨제이제일제당(주) | Corynebacterium sp. microorganisms having l-lysine-producing ability and method for producing l-lysine using same |
| US10961554B2 (en) | 2018-03-27 | 2021-03-30 | Cj Cheiljedang Corporation | Promoter and a method for producing L-amino acid using the same |
| WO2019190192A1 (en) * | 2018-03-27 | 2019-10-03 | 씨제이제일제당 (주) | Novel promoter, and method for producing l-amino acid by using same |
| US11661616B2 (en) | 2018-03-27 | 2023-05-30 | Cj Cheiljedang Corporation | Microorganism having increased glycine productivity and method for producing fermented composition using the same |
| CN115044490A (en) * | 2021-03-09 | 2022-09-13 | 大象株式会社 | Corynebacterium glutamicum mutant strain having improved L-lysine productivity and method for producing L-lysine using the same |
| WO2022191358A1 (en) * | 2021-03-09 | 2022-09-15 | 대상 주식회사 | Corynebacterium glutamicum variant having improved l-lysine production ability, and method for producing l-lysine by using same |
| CN115044490B (en) * | 2021-03-09 | 2024-03-29 | 大象株式会社 | Corynebacterium glutamicum mutant strain with improved L-lysine production capacity and L-lysine production method utilizing the same |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101492134B1 (en) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113544141B (en) | Microorganisms containing mutated LysE and methods of producing L-amino acids using the same | |
| JP6469874B2 (en) | New promoters and their uses | |
| CN105483145B (en) | Method for producing L-lysine using microorganism having L-lysine-producing ability | |
| KR101493585B1 (en) | Microorganisms for producing putrescine and process for producing putrescine using them | |
| JP6476212B2 (en) | Microbe of Corynebacterium that produces L-arginine and method for producing L-arginine using the same | |
| RU2665825C2 (en) | Putrescine producing microorganisms, and the putrescine production method by using these microorganisms | |
| EP3109318B1 (en) | Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them | |
| JP6286571B2 (en) | Corynebacterium microorganism having improved L-lysine production ability, and L-lysine production method using the same | |
| US11104925B2 (en) | Microorganism producing L-lysine and method for producing L-lysine using the same | |
| JP2018512132A (en) | Pyruvate dehydrogenase mutant, microorganism containing the same, and method for producing L-amino acid using the same | |
| KR101492134B1 (en) | Promoter variant of sod gene derived from coryneform bacteria and method for producing L-lysine using the promoter variant | |
| JP2020504598A (en) | Corynebacterium microorganism producing L-arginine and method for producing L-arginine using the same | |
| KR101640711B1 (en) | A gluconate repressor variant, a microorganism comprising the same and a method for producing L-lysine using the microorganism | |
| JP5814459B2 (en) | A Corynebacterium genus strain into which a fructokinase gene derived from an Escherichia genus strain has been introduced, and a method for producing an L-amino acid using the strain. | |
| US10787690B2 (en) | Microorganism of the genus Corynebacterium producing l-lysine and a method for producing l-lysine using the same | |
| KR101564753B1 (en) | Recombinant vector comprising start codon derived from Coryne form bacteria, transformed host cell and method for producing amino acid using the same | |
| CN114729378B (en) | Novel promoters and methods of using said promoters to produce desired substances | |
| RU2696504C2 (en) | Microorganism for producing diamine and a method of producing diamine using it | |
| RU2672323C2 (en) | Diamine-producing microorganism and method for producing diamine using same | |
| KR101495744B1 (en) | Recombinant vector comprising sod promoter derived from coryneform bacteria, transformed host cell and method for producing amino acid using the same | |
| EP3964572A1 (en) | Mutant of corynebacterium glutamicum with enhanced l-lysine productivity and method for preparing l-lysine using the same | |
| JP7683040B2 (en) | Corynebacterium glutamicum mutant with improved L-lysine production ability and method for producing L-lysine using the same | |
| KR101495742B1 (en) | Recombinant vector comprising sod promoter derived from coryneform bacteria, transformed host cell and method for producing amino acid using the same | |
| JP7362895B2 (en) | L-amino acid producing microorganism with enhanced cytochrome C activity and method for producing L-amino acid using the same | |
| JP2024538110A (en) | Corynebacterium glutamicum mutant with improved L-lysine production ability and method for producing L-lysine using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20120522 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20131126 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140520 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20141120 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20150204 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20150205 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| FPAY | Annual fee payment |
Payment date: 20180206 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20180206 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20210120 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240125 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250122 Start annual number: 11 End annual number: 11 |